NCT01178853

Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Kowa Research Institute, Inc. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is a Phase 4, single center, open label, 4 period, 2 treatment, crossover, drug-drug interaction study.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Warfarin	Warfarin 5 mg once daily
DRUG	Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)	Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)
DRUG	Warfarin 5 mg + Pitavastatin 4mg once daily (QD)	Warfarin 5 mg + Pitavastatin 4mg

Timeline

• Start date: 2010-07-01
• Primary completion: 2010-10-01
• Completion: 2011-04-01
• First posted: 2010-08-10
• Last updated: 2012-10-08
• Results posted: 2012-10-08

Locations

1 site across 1 country: United States